Back to Authors

McKenzie, Gavin

https://orcid.org/0000-0003-1544-6155

Mayo Clinic

Mayo Clinic

Citations 6

Palmar Fibromatosis, Updated Review With Relationship to the A1 Pulley, Trigger Finger, and Presence of the Sonographic Comb Sign
Pepperday, Cody A., Murthy, Naveen S. , McKenzie, Gavin , Murthy, Naveen, McKenzie, Gavin A , Pepperday, Cody A., Kakar, Sanjeev

Journal of Ultrasound in Medicine | August 23, 2024 | Volume: 43 | Issue: 12 | Pages: 2281-2293

10.1002/jum.16560 Get It

ObjectivesUpdated retrospective review of the sonographic appearance of palmar fibromatosis (PF) with evaluation of the utility of the Comb Sign previously described in plantar fibromas. Additional evaluation was conducted on the location relative to the flexor tendon, anatomic proximity of palmar fibromas to the A1 pulley and evaluate any potential association with trigger finger.MethodsMedical record and imaging review was performed from 2017 to 2023, for patients with a new onset ultrasound or clinical diagnosis of PF. Clinical associations and imaging morphology were reviewed including presence of the Comb Sign, fibroma association with the A1 pulley, and fibroma association with trigger finger.ResultsExactly 87 total fibromas in 53 patients were evaluated. The Comb Sign was present in 39% of fibromas, usually seen in transverse plane, more prevalent in multifocal disease and larger fibromas. Most (72%) palmar fibromas were within 1 cm of, contacted, or covered the A1 pulley (P < .001). Lateral extension beyond the flexor tendon axis can be seen (44%). Trigger finger and tenosynovitis were rare. However, volume and SI dimension of fibromas were associated with tenosynovitis (P < .0001) and all nine patients with concomitant trigger finger had fibromas within 1 cm from the A1 pulley.ConclusionsThe Comb Sign can aid in sonographic diagnosis of PF. Lateral extension of fibromas can occur. Most palmar fibromas have a significant intimate association with the A1 pulley, and presence of trigger finger with adjacent palmar fibroma can exist and is important for hand surgeons to know preoperatively.
Impact of flow pattern, body mass index, and age on intraprocedural fluoroscopic time and radiation dose during sacroiliac joint injections
Tiegs‐Heiden, Christin A. , Murthy, Naveen S. , Geske, Jennifer R. , Verdoorn, Jared T. , McKenzie, Gavin , Diehn, Felix E. , Lehman, Vance T. , Liebo, Greta B. , Verdoorn, Jared T , McKenzie, Gavin A , Tiegs-Heiden, Christin A , Geske, Jennifer , Carr, Carrie M.

The Neuroradiology Journal | March 9, 2021 | Volume: 34 | Issue: 5 | Pages: 428-434

10.1177/1971400921998966 Get It

Purpose Understanding all factors that may impact radiation dose and procedural time is crucial to safe and efficient image-guided interventions, such as fluoroscopically guided sacroiliac (SI) joint injections. The purpose of this study was to evaluate the effect of flow pattern (intra- vs. periarticular), patient age, and body mass index (BMI) on radiation dose and fluoroscopy time. Methods A total of 134 SI joint injections were reviewed. Injectate flow pattern, age, and BMI were analyzed in respect to fluoroscopy time (minutes), radiation dose (kerma area product (KAP); µGy m 2 ), and estimated skin dose (mGy). Results BMI did not affect fluoroscopy time, but increased BMI resulted in significantly higher skin and fluoroscopy doses ( p < 0.001). There was no association between fluoroscopy time and flow pattern. Higher skin dose was associated with intraarticular flow ( p = 0.0086), and higher KAP was associated with periarticular flow ( p = 0.0128). However, the odds ratios were close to 1. There was no significant difference between fluoroscopy time or dose based on patient age. Conclusion Increased BMI had the largest impact on procedural radiation dose and skin dose. Flow pattern also showed a statistically significant association with radiation dose and skin dose, but the clinical difference was small. Proceduralists should be aware that BMI has the greatest impact on fluoroscopy dose and skin dose during SI joint injections compared to other factors.
Multicentric reticulohistiocytosis: the Mayo Clinic experience (1980–2017)
Sánchez-Álvarez, Catalina , Sandhu, Avneek Singh, Crowson, Cynthia S. , Wetter, David A. , McKenzie, Gavin , Lehman, Julia S. , McKenzie, Gavin A , Makol, Ashima , Lehman, Julia S , Sanchez-Alvarez, Catalina

Rheumatology | October 21, 2019 | Volume: 59 | Issue: 8 | Pages: 1898-1905

10.1093/rheumatology/kez555 Get It

Abstract Objectives Multicentric reticulohistiocytosis (MRH), a rare histiocytic disease that can mimic other rheumatic conditions, may be associated with cancer and other autoimmune disorders. To better understand the disorder and its other associations, we aimed to evaluate clinical correlates and outcomes of all patients with MRH seen at Mayo Clinic, Rochester between 1980 and 2017. Methods A retrospective medical record review was conducted to identify all patients with MRH between 1 January 1980 and 30 April 2017. Results We identified 24 patients with biopsy-proven MRH (58% female, 75% Caucasian, median age at diagnosis 52 years, median follow-up of 2.3 years). All patients had cutaneous and articular involvement; 23 (96%) patients had papulonodular skin lesions (87% periungual and dorsal hand) and seven (30%) mucosal nodules; and 22 (92%) patients had arthralgias, 21 (88%) joint effusions and 13 (54%) synovitis. Most frequently used therapies included corticosteroids, cyclophosphamide, methotrexate and bisphosphonates. Biologics were used in four patients. Nine patients had symptomatic resolution at 1 year and 12 partial improvement. Radiological findings included erosive changes in three (60%) patients and arthritis mutilans in two patients (40%). Twenty-nine per cent of patients had a concomitant autoimmune disease and 25% malignancy including melanoma, endometrial, peritoneal and lung carcinoma. The 5-year survival rate was 85% (95% CI: 74, 100%). Conclusion To our knowledge, this is the largest single-centre series of patients with MRH highlighting the rarity of the condition and an unmet need for treatment options that can allow sustained disease remission. It also highlights the need for a high vigilance for malignancy and autoimmune diseases.
Synovial Cyst Direct Puncture, Overpressurization, and Rupture Under Fluoroscopy
Kim, Dong Kun , McKenzie, Gavin , McKenzie, Gavin A

Pain Medicine | October 24, 2018 | Volume: 20 | Issue: 3 | Pages: 575-577

10.1093/pm/pny264 Get It

Accessory Sacroiliac Joint Injection for Relief of Buttock Pain
Kim, Dong Kun , McKenzie, Gavin , McKenzie, Gavin A

Pain Medicine | October 19, 2018 | Volume: 20 | Issue: 2 | Pages: 412-413

10.1093/pm/pny254 Get It

Ultrasonography of Plantar Fibromatosis: Updated Case Series, Review of the Literature, and a Novel Descriptive Appearance Termed the “Comb Sign”
Cohen, Blake E., Murthy, Naveen S. , McKenzie, Gavin , McKenzie, Gavin A

Journal of Ultrasound in Medicine | March 31, 2018 | Volume: 37 | Issue: 11 | Pages: 2725-2731

10.1002/jum.14615 Get It

The purpose of this series is to review the appearance of plantar fibromatosis with high‐resolution ultrasonography (US) and highlight a new imaging sign termed the “comb sign.” A retrospective study was performed for patients with a clinical diagnosis of plantar fibromatosis. Charts of 43 patients (age range, 26–77 years; mean age, 54 years) were reviewed to gather patient demographics and symptoms. Several US characteristics were evaluated with emphasis on any new imaging features. A total of 57 plantar fibromas in 43 patients were examined. Plantar fibromatosis was seen as a lobular marginated oval nodule along the superficial plantar fascia involving the central or medial cord, often at the middle third (84%) of the plantar fascia, showing posterior acoustic enhancement (65%), mixed echogenicity (82%), and intralesional vascularity (53%). Slightly more than half (51%) of the lesions showed a previously unrecognized appearance, designated the comb sign. This sign was more commonly seen in the setting of larger fibromas (P < .05). Plantar fibromatosis is usually a clinical diagnosis that can be aided by a typical US appearance. Although the imaging characteristics are largely similar to prior literature, this series suggests that most show mixed echogenicity and posterior acoustic enhancement, and approximately half show internal vascularity. A new US sign, termed the comb sign, shows alternating bands of hypoechogenicity and isoechogenicity, particularly in larger plantar fibromas, and can help in further characterization.